Plus Therapeutics, Inc. (PSTV) — Analyst estimates
Consensus analyst estimates for Plus Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 3.03M | -0.7 | 1 |
| 2027 | 4.54M | -0.57 | 1 |
| 2028 | 10.85M | -0.64 | 1 |
| 2029 | 121.32M | 1.67 | 1 |
| 2030 | 173.26M | 2.97 | 1 |
Consensus analyst estimates by fiscal year.